A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.
EN20-01: A 24 Week Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Moderate to Severe Knee Osteoarthritis Pain.
Sponsor: Maurizio Fava, MD
A PHASE2 clinical study on Knee Osteoarthritis, this trial is completed. The trial is conducted by Maurizio Fava, MD and has accumulated 18 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
18 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE2
-
Sep 2025 — Dec 2025 [monthly]
Completed PHASE2
-
Oct 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Completed PHASE2
▶ Show 13 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Feb 2024 — Mar 2024 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Dec 2023 — Feb 2024 [monthly]
Recruiting PHASE2
-
Jul 2023 — Dec 2023 [monthly]
Recruiting PHASE2
-
Apr 2023 — Jul 2023 [monthly]
Recruiting PHASE2
-
Mar 2023 — Apr 2023 [monthly]
Recruiting PHASE2
-
Sep 2022 — Mar 2023 [monthly]
Recruiting PHASE2
-
Apr 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
Mar 2022 — Apr 2022 [monthly]
Recruiting PHASE2
-
Nov 2021 — Mar 2022 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Maurizio Fava, MD
For direct contact, visit the study record on ClinicalTrials.gov .